The ambulatory IV infusion pumps market size has grown steadily in recent years. It will grow from $0.86 billion in 2024 to $0.89 billion in 2025 at a compound annual growth rate (CAGR) of 3.5%. The growth in the historic period can be attributed to rapid growth in the elderly population, economic growth in emerging markets, and technological advancements.
The ambulatory IV infusion pumps market size is expected to see strong growth in the next few years. It will grow to $1.11 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to the increasing prevalence of chronic diseases, increasing demand for improved infusion pumps, COVID-19 impact, rise in healthcare expenditure, and increasing oncology cases in the geriatric population. Major trends in the forecast period include focusing on smart ambulatory infusion pump devices and software, developing new products, deploying technologies, and considering acquiring smaller drug delivery device companies.
The escalating prevalence of chronic conditions such as chronic pain, cancer, and diabetes has become a significant driver for the ambulatory IV infusion pumps market. These pumps play a pivotal role in delivering pharmaceutical drugs vital for treating these diseases. With chronic illnesses witnessing a surge globally due to factors such as an aging population and shifts in societal behaviors, the demand for ambulatory IV infusion pumps - essential in administering chemotherapy drugs, pain relief medications, antibiotics, insulin, among others - has grown substantially. According to the World Health Organization's report in September 2023, chronic diseases account for approximately 74% of global deaths, totaling 41 million fatalities annually. This increasing prevalence underscores the market's anticipated growth in ambulatory IV infusion pumps.
The growth trajectory of the ambulatory IV infusion pumps market is further fueled by the increasing count of surgical procedures. These procedures involve medical interventions, often requiring controlled and precise administration of fluids, medications, and anesthetics, which the ambulatory IV infusion pumps provide. The pumps' ability to ensure accurate and continuous delivery of substances during surgeries significantly contributes to patient safety and the overall efficiency of surgical processes. For instance, data from the British Heart Foundation in January 2022 indicated nearly 284,000 individuals awaited critical heart-related operations and procedures in England by the end of November 2021. As these procedures continue to rise, the demand for ambulatory IV infusion pumps as a crucial tool in surgical settings is expected to grow in tandem.
Companies within the ambulatory IV infusion pump market are increasingly directing their efforts toward the development of smart infusion pumps. This shift aligns with the growing utilization of wireless technology in health monitoring devices, offering enhanced ease of use, connectivity, and data analysis capabilities. The integration of wireless functionality enables seamless data transfer from the device to smartphones or wireless devices using Bluetooth or cellular connections. This data is then processed for analysis, and the results are displayed, facilitating further study and assessment of an individual's health condition. Moreover, the introduction of software platforms designed for patient monitoring aims to minimize human error and streamline data-driven healthcare practices.
Major players in the ambulatory IV infusion pumps market are intensifying their focus on introducing safe infusion therapy solutions to optimize market revenue. These solutions encompass a comprehensive range of practices and protocols crafted to administer intravenous medications, fluids, and therapeutic agents with paramount emphasis on patient safety, reduced complication risks, and improved treatment outcomes. A notable example is Baxter International Inc.'s achievement in August 2022, gaining US Food and Drug Administration (FDA) clearance for the Novum IQ syringe infusion pump integrated with Dose IQ Safety Software. This innovative pump is engineered to deliver minute fluid volumes, including medications, parenteral nutrition, blood products, and enteral nutrition, at low flow rates. It seamlessly interfaces with hospital electronic medical records (EMRs) through Baxter's IQ Enterprise Connectivity Suite, ensuring compatibility with legally sanctioned administration sets, syringes, and medications for safe and effective usage.
In March 2022, Fresenius Kabi, a German pharmaceutical company, successfully acquired Ivenix for an upfront payment of $240 million, along with additional milestone payments. This strategic acquisition is aimed at accelerating innovation, expanding and enhancing the infusion therapy portfolio, and improving infusion capabilities for both companies. Ivenix, based in the United States, is recognized as a manufacturer of advanced infusion pumps, and its integration into Fresenius Kabi is expected to strengthen the capabilities and offerings in the field of infusion therapy.
Major companies operating in the ambulatory IV infusion pumps market include Becton Dickinson and Company, Baxter International, B. Braun Holding GmbH & Co. KG, Smiths Medical, ICU Medical Inc., Fresenius Kabi, Terumo Corporation, Medtronic, IRadimed Corporation, Nipro Corporation, Sinomdt, Mindray, SCHILLER Healthcare India Pvt. Ltd., Johnson & Johnson, GE Healthcare, Covidien Healthcare India Private Limited, Accord Medical Products Private Limited, Shinva Medical Instrument Company Limited, Shandong WeiGao Group Medical Polymer Company Limited, Lepu Medical Technology Company (Beijing) Co. Ltd, Yuwell - Jiangsu Yuyue Medical Equipment & Supply Co. Ltd, Shanghai Runda Medical Technology Co. Ltd., Ambu Inc., Teleflex Medical, Beckman Coulter, St. Jude, Philips Healthcare, Draegerwerk AG, Masimo, 3M, Eitan Group, Q Core Medical.
North America was the largest region in the ambulatory IV infusion pumps market in 2024. Western Europe was the second largest region in the global ambulatory IV infusion pump market. The regions covered in the ambulatory IV infusion pumps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ambulatory IV infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.
Ambulatory IV infusion pumps are portable medical devices designed for the controlled delivery of medication into the patient's body.
The ambulatory IV infusion pumps market, as covered in this report, is segmented by type into disposable infusion pumps and chemotherapy infusion pumps. Disposable infusion pumps are single-use devices utilized for the controlled delivery of medication into the patient's body. These pumps find applications in various medical fields such as chemotherapy/oncology, diabetes, gastroenterology, analgesia/pain management, pediatrics/neonatology, hematology, and other medical applications. These devices are employed by a range of end-users including hospitals, home healthcare, and others.
The ambulatory IV infusion pumps market research report is one of a series of new reports that provides ambulatory IV infusion pumps market statistics, including ambulatory IV infusion pumps industry global market size, regional shares, competitors with a ambulatory IV infusion pumps market share, detailed ambulatory IV infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the ambulatory IV infusion pumps industry. This ambulatory IV infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The ambulatory IV infusion pumps market consists of sales of disposable infusion pumps and chemotherapy infusion pumps. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The ambulatory IV infusion pumps market size is expected to see strong growth in the next few years. It will grow to $1.11 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to the increasing prevalence of chronic diseases, increasing demand for improved infusion pumps, COVID-19 impact, rise in healthcare expenditure, and increasing oncology cases in the geriatric population. Major trends in the forecast period include focusing on smart ambulatory infusion pump devices and software, developing new products, deploying technologies, and considering acquiring smaller drug delivery device companies.
The escalating prevalence of chronic conditions such as chronic pain, cancer, and diabetes has become a significant driver for the ambulatory IV infusion pumps market. These pumps play a pivotal role in delivering pharmaceutical drugs vital for treating these diseases. With chronic illnesses witnessing a surge globally due to factors such as an aging population and shifts in societal behaviors, the demand for ambulatory IV infusion pumps - essential in administering chemotherapy drugs, pain relief medications, antibiotics, insulin, among others - has grown substantially. According to the World Health Organization's report in September 2023, chronic diseases account for approximately 74% of global deaths, totaling 41 million fatalities annually. This increasing prevalence underscores the market's anticipated growth in ambulatory IV infusion pumps.
The growth trajectory of the ambulatory IV infusion pumps market is further fueled by the increasing count of surgical procedures. These procedures involve medical interventions, often requiring controlled and precise administration of fluids, medications, and anesthetics, which the ambulatory IV infusion pumps provide. The pumps' ability to ensure accurate and continuous delivery of substances during surgeries significantly contributes to patient safety and the overall efficiency of surgical processes. For instance, data from the British Heart Foundation in January 2022 indicated nearly 284,000 individuals awaited critical heart-related operations and procedures in England by the end of November 2021. As these procedures continue to rise, the demand for ambulatory IV infusion pumps as a crucial tool in surgical settings is expected to grow in tandem.
Companies within the ambulatory IV infusion pump market are increasingly directing their efforts toward the development of smart infusion pumps. This shift aligns with the growing utilization of wireless technology in health monitoring devices, offering enhanced ease of use, connectivity, and data analysis capabilities. The integration of wireless functionality enables seamless data transfer from the device to smartphones or wireless devices using Bluetooth or cellular connections. This data is then processed for analysis, and the results are displayed, facilitating further study and assessment of an individual's health condition. Moreover, the introduction of software platforms designed for patient monitoring aims to minimize human error and streamline data-driven healthcare practices.
Major players in the ambulatory IV infusion pumps market are intensifying their focus on introducing safe infusion therapy solutions to optimize market revenue. These solutions encompass a comprehensive range of practices and protocols crafted to administer intravenous medications, fluids, and therapeutic agents with paramount emphasis on patient safety, reduced complication risks, and improved treatment outcomes. A notable example is Baxter International Inc.'s achievement in August 2022, gaining US Food and Drug Administration (FDA) clearance for the Novum IQ syringe infusion pump integrated with Dose IQ Safety Software. This innovative pump is engineered to deliver minute fluid volumes, including medications, parenteral nutrition, blood products, and enteral nutrition, at low flow rates. It seamlessly interfaces with hospital electronic medical records (EMRs) through Baxter's IQ Enterprise Connectivity Suite, ensuring compatibility with legally sanctioned administration sets, syringes, and medications for safe and effective usage.
In March 2022, Fresenius Kabi, a German pharmaceutical company, successfully acquired Ivenix for an upfront payment of $240 million, along with additional milestone payments. This strategic acquisition is aimed at accelerating innovation, expanding and enhancing the infusion therapy portfolio, and improving infusion capabilities for both companies. Ivenix, based in the United States, is recognized as a manufacturer of advanced infusion pumps, and its integration into Fresenius Kabi is expected to strengthen the capabilities and offerings in the field of infusion therapy.
Major companies operating in the ambulatory IV infusion pumps market include Becton Dickinson and Company, Baxter International, B. Braun Holding GmbH & Co. KG, Smiths Medical, ICU Medical Inc., Fresenius Kabi, Terumo Corporation, Medtronic, IRadimed Corporation, Nipro Corporation, Sinomdt, Mindray, SCHILLER Healthcare India Pvt. Ltd., Johnson & Johnson, GE Healthcare, Covidien Healthcare India Private Limited, Accord Medical Products Private Limited, Shinva Medical Instrument Company Limited, Shandong WeiGao Group Medical Polymer Company Limited, Lepu Medical Technology Company (Beijing) Co. Ltd, Yuwell - Jiangsu Yuyue Medical Equipment & Supply Co. Ltd, Shanghai Runda Medical Technology Co. Ltd., Ambu Inc., Teleflex Medical, Beckman Coulter, St. Jude, Philips Healthcare, Draegerwerk AG, Masimo, 3M, Eitan Group, Q Core Medical.
North America was the largest region in the ambulatory IV infusion pumps market in 2024. Western Europe was the second largest region in the global ambulatory IV infusion pump market. The regions covered in the ambulatory IV infusion pumps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ambulatory IV infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.
Ambulatory IV infusion pumps are portable medical devices designed for the controlled delivery of medication into the patient's body.
The ambulatory IV infusion pumps market, as covered in this report, is segmented by type into disposable infusion pumps and chemotherapy infusion pumps. Disposable infusion pumps are single-use devices utilized for the controlled delivery of medication into the patient's body. These pumps find applications in various medical fields such as chemotherapy/oncology, diabetes, gastroenterology, analgesia/pain management, pediatrics/neonatology, hematology, and other medical applications. These devices are employed by a range of end-users including hospitals, home healthcare, and others.
The ambulatory IV infusion pumps market research report is one of a series of new reports that provides ambulatory IV infusion pumps market statistics, including ambulatory IV infusion pumps industry global market size, regional shares, competitors with a ambulatory IV infusion pumps market share, detailed ambulatory IV infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the ambulatory IV infusion pumps industry. This ambulatory IV infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The ambulatory IV infusion pumps market consists of sales of disposable infusion pumps and chemotherapy infusion pumps. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Ambulatory IV infusion Pumps Market Characteristics3. Ambulatory IV infusion Pumps Market Trends and Strategies4. Ambulatory IV infusion Pumps Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid and Recovery on the Market32. Global Ambulatory IV infusion Pumps Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Ambulatory IV infusion Pumps Market34. Recent Developments in the Ambulatory IV infusion Pumps Market
5. Global Ambulatory IV infusion Pumps Growth Analysis and Strategic Analysis Framework
6. Ambulatory IV infusion Pumps Market Segmentation
7. Ambulatory IV infusion Pumps Market Regional and Country Analysis
8. Asia-Pacific Ambulatory IV infusion Pumps Market
9. China Ambulatory IV infusion Pumps Market
10. India Ambulatory IV infusion Pumps Market
11. Japan Ambulatory IV infusion Pumps Market
12. Australia Ambulatory IV infusion Pumps Market
13. Indonesia Ambulatory IV infusion Pumps Market
14. South Korea Ambulatory IV infusion Pumps Market
15. Western Europe Ambulatory IV infusion Pumps Market
16. UK Ambulatory IV infusion Pumps Market
17. Germany Ambulatory IV infusion Pumps Market
18. France Ambulatory IV infusion Pumps Market
19. Italy Ambulatory IV infusion Pumps Market
20. Spain Ambulatory IV infusion Pumps Market
21. Eastern Europe Ambulatory IV infusion Pumps Market
22. Russia Ambulatory IV infusion Pumps Market
23. North America Ambulatory IV infusion Pumps Market
24. USA Ambulatory IV infusion Pumps Market
25. Canada Ambulatory IV infusion Pumps Market
26. South America Ambulatory IV infusion Pumps Market
27. Brazil Ambulatory IV infusion Pumps Market
28. Middle East Ambulatory IV infusion Pumps Market
29. Africa Ambulatory IV infusion Pumps Market
30. Ambulatory IV infusion Pumps Market Competitive Landscape and Company Profiles
31. Ambulatory IV infusion Pumps Market Other Major and Innovative Companies
35. Ambulatory IV infusion Pumps Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Ambulatory IV infusion Pumps Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on ambulatory iv infusion pumps market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for ambulatory iv infusion pumps? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ambulatory iv infusion pumps market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Therapy: Chemotherapy Infusion Pumps, Anti-Infective Infusion Pumps, Other Therapies2) By Application: Chemotherapy or Oncology, Diabetes, Gastroenterology, Analgesia or Pain Management, Pediatrics or Neonatology, Hematology, Anti-Infective, Other Applications
3) By Patient Care Setting: Hospitals, Home Healthcare, Other End Users
Subsegments:
1) By Chemotherapy Infusion Pumps: Continuous Chemotherapy Infusion Pumps; Cyclic Chemotherapy Infusion Pumps; Patient-Controlled Analgesia (PCA) Pumps for Chemotherapy2) By Anti-Infective Infusion Pumps: Antibiotic Infusion Pumps; Antiviral Infusion Pumps; Antifungal Infusion Pumps
3) By Other Therapies: Pain Management Infusion Pumps; Nutritional Infusion Pumps (Total Parenteral Nutrition); Hormonal Therapy Infusion Pumps; Hydration Infusion Pumps
Key Companies Mentioned: Becton Dickinson and Company; Baxter International; B. Braun Holding GmbH & Co. KG; Smiths Medical; ICU Medical Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Becton Dickinson and Company
- Baxter International
- B. Braun Holding GmbH & Co. KG
- Smiths Medical
- ICU Medical Inc.
- Fresenius Kabi
- Terumo Corporation
- Medtronic
- IRadimed Corporation
- Nipro Corporation
- Sinomdt
- Mindray
- SCHILLER Healthcare India Pvt. Ltd.
- Johnson & Johnson
- GE Healthcare
- Covidien Healthcare India Private Limited
- Accord Medical Products Private Limited
- Shinva Medical Instrument Company Limited
- Shandong WeiGao Group Medical Polymer Company Limited
- Lepu Medical Technology Company (Beijing) Co. Ltd
- Yuwell - Jiangsu Yuyue Medical Equipment & Supply Co. Ltd
- Shanghai Runda Medical Technology Co. Ltd.
- Ambu Inc.
- Teleflex Medical
- Beckman Coulter
- St. Jude
- Philips Healthcare
- Draegerwerk AG
- Masimo
- 3M
- Eitan Group
- Q Core Medical
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 175 |
| Published | March 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 0.89 Billion |
| Forecasted Market Value ( USD | $ 1.11 Billion |
| Compound Annual Growth Rate | 5.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 32 |
